Literature DB >> 7654282

Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.

.   

Abstract

The fungus Pneumocystis carinii, which rarely if ever causes illness in otherwise healthy people, can cause potentially fatal pneumonia in patients with defects of cell-mediated immunity resulting, for example, from chemotherapy or immunosuppression after organ transplantation. P. carinii pneumonia also occurs in up to 85% of patients with acquired immunodeficiency syndrome (AIDS), in many of whom it is the first manifestation of the disease. This article discusses the prevention and treatment of P. carinii pneumonia in adults infected with the human immunodeficiency virus (HIV).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7654282     DOI: 10.1136/dtb.1994.32212

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  3 in total

1.  The management of Pneumocystis carinii pneumonia.

Authors:  F J Vilar; S H Khoo; T Walley
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

2.  Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Authors:  Robert F Miller; Austin R Lindley; Helen E Ambrose; Adam S Malin; Ann E Wakefield
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 3.  AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.